Birdwatch Note
2024-03-20 15:34:03 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Las avermectinas son derivados macrocíclicos de la lactona producidas por la actinobacteria Streptomyces avermitilis. Son para infecciones de gusanos parásitos, no enfermedades de origen viral como el COVID. https://www.fda.gov/consumers/articulos-para-el-consumidor-en-espanol/por-que-no-debe-utilizar-la-ivermectina-para-tratar-o-prevenir-el-covid-19#:~:text=La%20ivermectina%20est%C3%A1%20aprobada%20para,eficaz%20contra%20el%20COVID%2D19.
Written by F337A1E9F13E6D0CA505B576B82F23C98A183D5CB742325973D05DADEE44E065
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1770438251800567834
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1770473888075440624
- noteId - 1770473888075440624
- participantId -
- noteAuthorParticipantId - F337A1E9F13E6D0CA505B576B82F23C98A183D5CB742325973D05DADEE44E065 Participant Details
- createdAtMillis - 1710948843388
- tweetId - 1770438251800567834
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Las avermectinas son derivados macrocíclicos de la lactona producidas por la actinobacteria Streptomyces avermitilis. Son para infecciones de gusanos parásitos, no enfermedades de origen viral como el COVID. https://www.fda.gov/consumers/articulos-para-el-consumidor-en-espanol/por-que-no-debe-utilizar-la-ivermectina-para-tratar-o-prevenir-el-covid-19#:~:text=La%20ivermectina%20est%C3%A1%20aprobada%20para,eficaz%20contra%20el%20COVID%2D19.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-20 15:34:03 UTC (1710948843388) |
2024-03-21 01:30:52 UTC (1710984652589) |
CURRENTLY_RATED_HELPFUL | 2024-03-21 01:30:52 UTC (1710984652589) |
CURRENTLY_RATED_HELPFUL | 2024-03-21 01:30:52 UTC (1710984652589) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-20 19:02:37 -0500 | Rating Details | |
2024-03-20 16:50:52 -0500 | Rating Details | |
2024-03-20 16:34:26 -0500 | Rating Details | |
2024-03-20 16:20:53 -0500 | Rating Details | |
2024-03-20 15:18:32 -0500 | Rating Details | |
2024-03-20 14:14:48 -0500 | Rating Details | |
2024-03-20 13:48:55 -0500 | Rating Details | |
2024-03-20 13:33:38 -0500 | Rating Details | |
2024-03-20 13:28:30 -0500 | Rating Details | |
2024-03-20 13:25:13 -0500 | Rating Details | |
2024-03-20 13:18:22 -0500 | Rating Details | |
2024-03-20 13:00:46 -0500 | Rating Details | |
2024-03-20 12:52:42 -0500 | Rating Details | |
2024-03-20 12:51:28 -0500 | Rating Details | |
2024-03-20 12:47:47 -0500 | Rating Details | |
2024-03-20 12:40:24 -0500 | Rating Details | |
2024-03-20 12:39:00 -0500 | Rating Details | |
2024-03-20 12:20:04 -0500 | Rating Details | |
2024-03-20 11:14:21 -0500 | Rating Details | |
2024-03-20 11:03:34 -0500 | Rating Details | |
2024-03-20 10:49:22 -0500 | Rating Details | |
2024-03-21 15:23:21 -0500 | Rating Details | |
2024-03-21 10:29:33 -0500 | Rating Details | |
2024-03-21 07:31:14 -0500 | Rating Details | |
2024-03-21 04:05:03 -0500 | Rating Details | |
2024-03-21 01:50:24 -0500 | Rating Details | |
2024-03-21 00:47:57 -0500 | Rating Details | |
2024-03-20 22:34:47 -0500 | Rating Details | |
2024-03-21 23:10:53 -0500 | Rating Details | |
2024-03-21 12:12:05 -0500 | Rating Details | |
2024-03-21 12:04:00 -0500 | Rating Details | |
2024-03-21 10:27:32 -0500 | Rating Details | |
2024-03-21 07:29:27 -0500 | Rating Details | |
2024-03-21 06:20:05 -0500 | Rating Details | |
2024-03-21 06:13:32 -0500 | Rating Details | |
2024-03-21 05:33:11 -0500 | Rating Details | |
2024-03-20 22:42:02 -0500 | Rating Details | |
2024-03-20 20:51:20 -0500 | Rating Details | |
2024-03-20 20:18:22 -0500 | Rating Details | |
2024-03-20 17:00:20 -0500 | Rating Details | |
2024-03-20 16:34:21 -0500 | Rating Details | |
2024-03-20 16:34:20 -0500 | Rating Details | |
2024-03-20 15:35:09 -0500 | Rating Details | |
2024-03-20 15:30:12 -0500 | Rating Details | |
2024-03-20 14:49:54 -0500 | Rating Details | |
2024-03-20 14:38:58 -0500 | Rating Details | |
2024-03-20 13:37:27 -0500 | Rating Details | |
2024-03-20 12:54:32 -0500 | Rating Details | |
2024-03-20 12:18:30 -0500 | Rating Details | |
2024-03-20 11:56:21 -0500 | Rating Details | |
2024-03-20 11:54:01 -0500 | Rating Details | |
2024-03-20 11:49:26 -0500 | Rating Details | |
2024-03-20 11:31:00 -0500 | Rating Details | |
2024-03-20 11:26:12 -0500 | Rating Details | |
2024-03-20 11:04:53 -0500 | Rating Details | |
2024-03-20 11:04:06 -0500 | Rating Details | |
2024-03-20 10:55:20 -0500 | Rating Details | |
2024-03-20 10:38:46 -0500 | Rating Details | |
2024-03-21 10:34:33 -0500 | Rating Details | |
2024-03-21 05:19:17 -0500 | Rating Details | |
2024-03-21 00:03:18 -0500 | Rating Details | |
2024-03-20 22:40:09 -0500 | Rating Details | |
2024-03-20 18:54:07 -0500 | Rating Details | |
2024-03-20 17:25:14 -0500 | Rating Details | |
2024-03-20 17:09:00 -0500 | Rating Details | |
2024-03-20 17:00:51 -0500 | Rating Details | |
2024-03-20 16:51:38 -0500 | Rating Details | |
2024-03-20 16:37:15 -0500 | Rating Details | |
2024-03-20 16:27:45 -0500 | Rating Details | |
2024-03-20 16:17:21 -0500 | Rating Details | |
2024-03-20 16:16:05 -0500 | Rating Details | |
2024-03-20 15:32:21 -0500 | Rating Details | |
2024-03-20 13:56:39 -0500 | Rating Details | |
2024-03-20 13:48:18 -0500 | Rating Details | |
2024-03-20 13:48:08 -0500 | Rating Details | |
2024-03-20 13:47:53 -0500 | Rating Details | |
2024-03-20 13:39:32 -0500 | Rating Details | |
2024-03-20 13:01:02 -0500 | Rating Details | |
2024-03-20 12:57:02 -0500 | Rating Details | |
2024-03-20 12:43:52 -0500 | Rating Details | |
2024-03-20 12:30:14 -0500 | Rating Details | |
2024-03-20 12:10:41 -0500 | Rating Details | |
2024-03-20 12:03:48 -0500 | Rating Details | |
2024-03-20 11:35:11 -0500 | Rating Details | |
2024-03-20 11:31:55 -0500 | Rating Details | |
2024-03-20 11:12:36 -0500 | Rating Details | |
2024-03-20 11:09:43 -0500 | Rating Details | |
2024-03-20 10:57:16 -0500 | Rating Details | |
2024-03-20 10:38:35 -0500 | Rating Details |